This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Won Ki Kang
Introduction
Won Ki Kang is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, which has implications for treating various cancers.
Latest Patents
Won Ki Kang holds 1 patent related to his research. His patent details methods of treating various cancers, such as prostatic adenocarcinoma, using inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG Co-A), including lovastatin. The patent also outlines dosing ranges, schedules, and potential toxicities associated with these treatments.
Career Highlights
Throughout his career, Won Ki Kang has been dedicated to advancing medical science and improving treatment options for cancer patients. His innovative approach has garnered attention in the medical community, and his work continues to influence ongoing research in cancer therapies.
Collaborations
Won Ki Kang has collaborated with notable colleagues, including Jane B Trepel and Luke Whitesell. These partnerships have enhanced the scope and impact of his research, contributing to the development of effective cancer treatment methods.
Conclusion
Won Ki Kang's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work exemplifies the importance of research and collaboration in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile